Dr Bill Nelson and Dr Nilo Azad discuss the decades-long research effort to develop treatments targeting KRAS mutations and the importance of federal funding in bringing those treatments to patients.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
